Advertisement

Topics

Changing the finish line: Syneos talks bringing payer, patient voice into drug development

10:35 EDT 19 Jun 2018 | Outsourcing-Pharma

The drug development âfinish lineâ is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.

Original Article: Changing the finish line: Syneos talks bringing payer, patient voice into drug development

NEXT ARTICLE

More From BioPortfolio on "Changing the finish line: Syneos talks bringing payer, patient voice into drug development"

Advertisement
Quick Search
Advertisement
Advertisement